share_log

中信证券股份有限公司关于益方生物科技(上海)股份有限公司2024年半年度持续督导跟踪报告

CITIC Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Yifang Biotechnology (Shanghai) Co., Ltd.

SZSI ·  Sep 13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more